Type | Prevalence | Elevated lipoprotein | Fredrickson type | Appearance of serum on standing | Gene defect |
Familial chylomicronaemia | |||||
Familial LPL deficiency | 1/1000000 | CM | I | Creamy supernatant, clear infranate | AR, LPL,115 ApoC-II116 or ApoAV deficiency,11 heterozygotes may have a mild abnormality |
Familial ApoC-II or ApoAV deficiency | <1/1000000 | CM | I | ||
Familial combined hyperlipidaemia | 1–6% | LDL + VLDL | IIb | Turbid | AD/oligogenetic?* |
Familial dysbetalipoproteinemia | 1/10000114 | IDL | III | Milky | ApoE-II homozygosity, AR, requires second abnormality for expression |
Familial hyperlipidaemia | 0.2–0.5% | VLDL | IIb | Turbid | Multiple, AD |
Familial mixed hypertriglyceridaemia | <1/1000000 | CM + VLDL | V | Creamy supernatant, turbid infranatant | Multiple, AR |
While the genetic abnormalities associated with familial chylomicronaemia and familial dysbetalipoproteinaemia have been clarified, the primary triglyceridaemias are known to be modified by other genetic and environmental determinants. The Fredrickson classification is of little use in clinical practice, though it remains in common parlance.
*There is likely to be an overlap between the underlying metabolic defects associated with familial combined dyslipidaemia, the dyslipidaemia associated with insulin resistance and familial hypertriglyceridaemia.
AD, autosomal dominant; Apo, apolipoprotein; AR, autosomal recessive; CM, carboxymethylated; IDL, intermediate density lipoprotein; LDL, low density lipoprotein; VLDL, very low density lipoprotein.